Status of Management of Surgery in Beijing During COVID-19

• Conditions: Gastrointestinal Disease; Gastric Cancer; Colorectal Cancer
• Interventions: Other: no intervention

• Registration Number: NCT04401124
• Lead Sponsor: Beijing Friendship Hospital

Brief Summary

This is a multi-centered, retrospective, observational study aimed at observing the current status of the management of gastrointestinal surgery during the COVID-19 pandemic, particularly the changes on surgery protocols and other key aspects of surgical workflow, so as to share experience with colleagues both domestic and abroad.

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-05
• Study First Submitted: 2020-05-22
• Study First Submitted QC: 2020-05-22
• Last Update Submitted: 2020-05-22
• Study Start: 2020-05-25
• Study First Posted: 2020-05-26
• Last Update Posted: 2020-05-27
• Primary Completion: 2020-05-31
• Study Completion: 2020-06-07

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• All patients arriving at surgical emergency and all patients receiving gastrointestinal surgeries in participating centers from 2020.1.1~2020.3.31.

Read More

Exclusion Criteria

• None

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
patients treated at surgical emergency rooms	no intervention	-
patients receiving surgeries (both elected and emergency)	no intervention	-

Primary Outcome Measures

Name	Time	Method
treatment of post-operative fevers	1 day	proportion of patients on whom fever occured, proportion of patients screened for COVID-19, method of screening (CT? nucleated acid test?)
treatment of fevers at arrival	1 day	proportion of patients presented with fever, proportion of patients refered to fever clinics, proportion of patients screened for COVID-19, method of screening (CT? nucleated acid test?)
assorted surgical parameters	1 day	Duration of operation (≥180min/\<180min); Intra-operative transfusion (Y/N); Surgical approach (Laparoscopy-involved/Open); Resection range (Non-radical/Radical); Lymph node dissection (Unknown/Not dissected/D1/D2 or above); Combined organ resection (Y/N); Post-operative complications (Y/N); Post-operative transfusion (Y/N); Post-operative hospital stay (≥7d/\<7d)

Secondary Outcome Measures

Name	Time	Method
hospitals' protection measures and extent of implementation	1 month	Out-patient of surgery (Open/Closed); Emergency of surgery (Open/Closed); Fever clinic (Open/Closed); Surgical ward (Open/Closed); Functional level of surgical ward (Receive emergency surgery patients only/Receive surgery patients only/Receive all kinds of patients); Isolation ward for suspected COVID-19 patients (With/Without); Bed number in each surgical ward room (1/2/≥3); Isolation area within surgical ward (With/Without); Usage of sub-pressure operation theaters (Routinely applied/Applied for suspected patients/Never applied); Protection level of surgeons in surgical ward (No specific protection/Regular medical masks/Any of N95 mask, eye/face shields, gowns); Protection level of surgeons in ER room (No specific protection/Regular medical masks/Any of N95 mask, eye shields, face shields, gowns)